Status:
UNKNOWN
Submucosal Saline Injection Followed by Endoscopic Ultrasound
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
Zhejiang Cancer Hospital
Sichuan Cancer Hospital and Research Institute
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Endoscopic ultrasound (EUS) is unsatisfactory in distinguishing between T1a and T1b stage esophageal squamous cell carcinoma (ESCC). Consequently, the National Comprehensive Cancer Network guidelines ...
Eligibility Criteria
Inclusion
- Age 18-75 years old, no gender limited;
- Patients with esophageal squamous cell carcinoma who be confirmed by ordinary endoscopy and pathologic biopsy;
- Patients who agree to accept endoscopic resection or surgical excision of the lesion in esophagus;
- patients with normal cardio-pulmonary function and normal coagulative function,are predicted to be tolerated anesthesia and surgery;
- patients who understand test purpose, volunteer to join these study and sign the consent inform.
Exclusion
- Patients with stages of T2, T3, or T4 displayed by EUS;
- Patients who can't tolerate endoscopy and surgical treatment for various reasons;
- Patients who have distant metastasis, or multiple source of malignant tumors;
- Patients with blood coagulative disorder;
- Patients don't accept the endoscopic examination or surgical treatment;
- Patients with poor compliancy.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT06022978
Start Date
January 1 2021
End Date
December 30 2024
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510080